Article Versions Notes

Gupta N, Gopal K, Wu C, Alshareef A, Chow A, Wu F, Wang P, Ye X, Bigras G, Lai R. Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Cancers. 2018; 10(2):41. https://doi.org/10.3390/cancers10020041

Gupta, Nidhi, Keshav Gopal, Chengsheng Wu, Abdulraheem Alshareef, Alexandra Chow, Fang Wu, Peng Wang, Xiaoxia Ye, Gilbert Bigras, and Raymond Lai. 2018. "Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features" Cancers 10, no. 2: 41. https://doi.org/10.3390/cancers10020041

Gupta, N., Gopal, K., Wu, C., Alshareef, A., Chow, A., Wu, F., Wang, P., Ye, X., Bigras, G., & Lai, R. (2018). Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features. Cancers, 10(2), 41. https://doi.org/10.3390/cancers10020041